Condition
Pelvic Neoplasm
Total Trials
6
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Unknown3
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06651697Phase 3RecruitingPrimary
BladdEr Full OR Empty for Pelvic Radiation Therapy
NCT05605353RecruitingPrimary
Exploiting the Gut Microbiota and Its Metabolites in Pelvic Cancer
NCT05258383Unknown
Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy Tests
NCT05683795Unknown
PelvEx - Beating the Empty Pelvis Syndrome
NCT03458598Not ApplicableCompleted
Pre-Operative Single Shot Rectus Sheath Block
NCT03168048Not ApplicableUnknown
Oncologic Therapy Support Via Means of a Dedicated Mobile App
Showing all 6 trials